Sickle Cell Disease Trial, Recruiting NCT06689800 Sponsor: Washington University School of Medicine Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT06689800
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For children and teenagers:

  • The child or teen is between 8 and 17 years old and has been referred for a stem cell or cellular therapy treatment
  • They have been diagnosed with either a cancerous or non-cancerous condition
  • They are scheduled to meet with a doctor to talk about stem cell or cellular therapy (any type is eligible, including transplants using their own or someone else's cells)
  • They are able to understand what the study involves and are willing to agree to take part
  • They speak English and are mentally able to take part in the study activities

For parents or guardians:

  • You are the parent or guardian of a child aged 8–17 who has been referred for stem cell or cellular therapy, and you are the person who usually cares for them and makes medical decisions for them
  • You are able to understand what the study involves and are willing to agree to take part
  • You speak English and are mentally able to take part in the study activities

Who may not be able to join:

For children and teenagers:

  • The child has serious medical problems at the time of joining that would prevent them from taking part
  • The child's main transplant doctor does not want them to take part in the study
  • The child does not have the mental ability to complete the study activities, as decided by the person managing consent

For parents or guardians:

  • The child has said they do not want to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine

Phone: 314-454-6018

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 November 2024
Est. completion
30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of intervention as measured by the Feasibility of Intervention questionnaire; Acceptability of intervention as measured by the Acceptability of Intervention questionnaire; Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire; Feasibility of intervention as measured qualitatively; Acceptability of intervention as measured qualitatively; Appropriateness of intervention as measured qualitatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov